Medipal Holdings is a holding company controls, administers and supports the operating activities of subsidiaries and affiliates in which it holds shares in the prescription pharmaceutical wholesale business, cosmetics, daily necessities and OTC pharmaceutical wholesale business, Animal health products and food processing raw materials wholesale business, and related business. Co. is involved in the wholesale of pharmaceutical products, medical equipment and test reagents; cosmetics, daily necessities, soap, detergents, over-the-counter pharmaceuticals; and veterinary products, food additives and food processing raw materials.
Suzuken is mainly engaged in the manufacture and sale of pharmaceutical products. Co. is engaged in the sale of pharmaceuticals and medical equipment; the manufacture of pharmaceutical products and diagnostic medicines; the operation of dispensing pharmacies; the provision of medical-related services, such as the sale of healthcare-related literature and the provision of clinical research coordinators; the provision of home nursing care and facility nursing care services; the manufacture of biological and physiological measuring equipment, such as electrocardiographic equipment and blood pressure gauges; as well as the transportation of pharmaceutical products.
Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.
Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.